0%
Daily Market Update
05-Oct-20261 min readvipin kumar

Gift Nifty trading higher while the US stock market rallied last week after weaker-than-expected jobs data reduced bets of Federal Reserve interest rate hike.- Daily Market Update 5th Oct 2026

Get a Smart Summary Instantly

Prompt copied

The Indian stock market is expected to open higher on Monday, after eight straight weeks of losses, following gains in global markets.

The trends on Gift Nifty also signal a positive start for the Indian benchmark indices, Nifty 50 and Sensex, today. The Gift Nifty was trading around 22,644 level, a premium of nearly 114 points from the Nifty futures’ previous close.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled higher in range 0.49% to 1.19%.
  • European equity markets also ended higher in range 0.78% to 1.16%.
  • The majority of Asian equity markets are trading in green.
  • GIFT Nifty is up by 140 points, Nifty futures likely to open around 22600 levels.

 

News highlights from across the globe

  • US stocks advanced on Friday to ​close out the trading week after weaker-than-expected jobs data dampened expectations for a rate hike from the Federal Reserve at its ‌policy meeting this month.
  • Asian markets are trading higher on Monday after softer US jobs data reduced pressure on the Federal Reserve to keep raising interest rates.
  • Crude oil prices rose on Monday after Yemen’s Iran-backed Houthis said they launched ballistic missiles and drones at Saudi Aramco sites, raising concerns about production at the top exporter in the region. Brent crude futures climbed 0.79% to $103.06 per barrel.

 

Important news updates from the domestic front

  • HDFC Bank appoints Anup Bagchi as Managing Director & CEO.
  • Gland Pharma to invest $21 million (approximately Rs 183 crore) in Gland Pharma USA; funds to be used for subscribing to 60% stake in Novelstar, which will become a subsidiary of Gland Pharma USA.
  • Coal India expects coal production and supplies to pick up further; targets 815 MT production and 850 MT supply in FY27. Supply to the power sector rose 10.63% YoY in Q2.
  • Redington signs distribution partnership with OPSWAT for critical infrastructure protection solutions across the Middle East, Turkiye, Africa and CIS regions.
  • Wipro completes acquisition of select customer contracts from Alpha Net Consulting; transaction closed on October 1.
  • Deepak Fertilisers receives an administrative warning and advisory letter from SEBI for non-disclosure of investments and guarantees to subsidiaries, and certain litigations exceeding materiality thresholds.
  • ICICI Bank receives a Rs 229 crore tax order from the Maharashtra tax authority.
    Sudarshan Chemical Industries completes acquisition of 15.89% stake in Sudarshan Colorants for Rs 151 crore.
  • Aarti Industries approves fundraising of up to Rs 1,000 crore through equity and debt instruments.
  • MRPL withdraws fuel export tenders following the fire incident; export tenders expected to be reissued after review.
  • Infosys partners with Columbia University to launch an Enterprise AI Center and research collaboration.
  • Titagarh Rail Systems shareholders approve reappointment of Jagdish Prasad Chowdhary as Executive Chairman and Anil Kumar Agarwal as Deputy Managing Director.
  • Punjab National Bank receives an administrative warning letter from SEBI; regulator warns three bank officials for alleged insider trading norm violations.
  • MRPL: Karnataka High Court upholds the company’s victory in a Rs 173 crore CENVAT
  • TCS completes acquisition of 100% stake in BBY Services India LLP for Rs 1 lakh.
  • Muthoot Finance shareholders approve Alexander George’s appointment as Managing Director and George Alexander Muthoot’s appointment as Vice Chairman effective Oct. 1.
  • Dr Lal PathLabs completes acquisition of stake in SN Genelab.
  • RVNL– East Coast Railway cancels order for IP-based video surveillance system.
  • Godrej Properties receives MoEFCC letter revoking environmental clearance for Chandigarh project ‘Godrej Eternia’; company to challenge order.
  • Balaji Amines receives SEBI warning-cum-advisory letter for non-submission of disclosure.
  • Piramal Pharma clarifies reports on $1.7 million investment in Aurora unit; Ontario grant to support Aurora site expansion under LSSUF programme.
  • Ashoka Buildcon extends deadline for sale of stake in Ashoka Baswantpur Singnodi Road to Oct. 31.
  • Ola Electric Mobility shareholders approve fundraising via issuance of securities.
  • Piramal Pharma to not renew sales and distribution pact with Bayer; agreement expires on Dec. 31.
  • Vedanta Aluminium Metal- Orissa High Court dismisses writ petition related to bauxite linkage policy provisions.
  • Zydus Lifesciences extends timeline to complete subscription of 50% stake in JV with Sunshine; transaction expected by December.
  • IREDA extends additional charge of CMD post to Bijay Kumar Mohanty for a further three months.
  • Bajaj Finance approved QIP up to Rs 11,700 crore and preferential warrants up to Rs 5,800 crore.
  • Bajaj Finserv approves up to Rs 5,800 crore warrant subscription in Bajaj Finance Ltd via preferential allotment.
  • ICICI Life appoints Sidharatha Mishra as MD & CEO from Oct. 14 for five years. Appoints Sidharatha Mishra as Chief Operating Officer from Oct. 6, 2026. Noted resignation of Anup Bagchi as MD & CEO on Oct. 13.
  • Indiabulls gets RBI nod as Core Investment Company. Gets Certificate of Registration from RBI.
  • Mazagon Dock clarifies on Thoothukudi shipyard exit reports. Selected as anchor yard for two shipbuilding hubs. Focused on Dighi, Dugarajapatnam clusters. Thoothukudi project not pursued after JV decision.
    Aurobindo Pharma: Arm Apitoria acquires A1 Biochem’s CRO business for $15.2 million.
  • Hindustan Aeronautics acquires remaining 50% stake in HATSOFF Helicopter. Buys 3.8 crore shares of HATSOFF Helicopter from CAE Canada. Converts JV company into arm.
  • Texmaco Rail & Engineering- West Central Railway has issued Letter of Acceptance for order of Rs 3.65 crore for provision of anti-bird disc for prevention of bird fault.
  • Wipro merger of arm Wipro VLSI Design Services into another arm Wipro IT Services completed and effective from Oct. 1.
  • Aurobindo Pharma gets USFDA final approval for Perampanel Tablets. Perampanel Tablets are used to treat partial-onset seizures.

 

Nifty Overview & Outlook

The benchmark Nifty index ended sharply lower at 22,421.95 spot levels, after a cut of 198.50 points from its previous closing values.

The broader markets also remained under pressure, with Nifty Small & Midcap falling over 1% each. Market breadth remained weak as the decline was broad-based.

The performance on the sectoral front was largely tilted towards the negative side. Nifty IT was the standout performer, gaining 2.17%. On the flip side, Nifty Auto was the worst performer, falling 3.46%, followed by Metal, Media, Consumer Durables, Realty, Oil & Gas and FMCG
index that fell in range 1.32% to 2.5%.

Technically, Nifty has approached the crucial 22200–22150 spot support zone, with the day’s low near 22,217. Hence, the possibility of a technical bounce towards 22600–22700 cannot be ruled out, particularly if the index sustains above 22,500 on a closing basis. However, the overall chart structure remains negative, and any recovery is likely to face selling pressure near 22600–22700. A decisive break below 22200 could extend the downside towards 22000–21900 levels.

 

Derivatives Overview & Outlook

On Thursday, Nifty and Finnifty futures settled lower on short buildup to the tune of around 7% & 6% of open interest respectively along with some long unwinding in Banknifty futures that shed around 1.5% of open interest. On the other hand, Midcapnifty futures ended lower by 1.3% without any change in open interest.

All F&O sectors, barring Technology stocks, settled lower on short buildup along with some long unwinding in Telecom stocks.

On options front, put writing along with some call unwinding was seen at multiple OTM strikes. Maximum positions are at 23000 CE followed by 23500 CE and 22000 PE followed by 21500 PE.

 

Institutional Trading Activity

Last week, FIIs sold stocks worth Rs 33882 Cr in the cash segment, bought stocks futures worth Rs 8643 Cr and also sold index futures worth Rs 8585 Cr. DIIs were net buyers in the cash segment to the tune of Rs 33456 Cr.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 22700-22900; Supports 22350-22200

Banknifty – Resistances 55300-56000; Supports 54200-54000

Finnifty – Resistances 24900-25100; Supports 24500- 24400

 

F&O stocks in ban today: Ambujacem, Sail & Bandhanbank

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates. AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited and Lakshya Impex Private Limited are the associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection GC does not take any responsibility thereof. This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months. GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months. Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document. Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Our research analysts may use AI tools to collect, summarize, and present data in order to increase productivity and enhance the clarity and readability of our reports. However, all reports are subject to human review prior to finalization and distribution to end users.

Our published research reports are the property of GCML and its associate and subsidiary companies. These reports may not be copied, reproduced, distributed or otherwise used by any other brokerage or individual firm without the prior written permission of GCML or its associate/subsidiary companies.